PayPal enters the week under twin pressure — a post-earnings selloff and a fresh UK regulatory investigation — while short sellers are quietly reducing their bets.
The price action this week tells the most urgent story. Shares fell 7.7% on May 5 to $46.49, erasing the modest 2.5% gain built through April. The selloff followed Q1 results that left the market dissatisfied. Headlines that day asked pointed questions about the company's future operating model, and news emerged that the UK's Financial Conduct Authority had opened a probe into alleged anti-competitive conduct at PayPal's digital wallet alongside Mastercard and Visa. The regulatory headline alone would have weighed on sentiment; layered on top of a Q1 read that failed to excite, the combination drove one of the sharper single-day moves of the year. CEO restructuring plans, reported across several outlets Wednesday, suggest the new leadership is still in the process of setting direction — which analysts have framed as a reason for patience rather than confidence.
Despite the price drop, short sellers are not piling in. Short interest has been drifting lower for weeks, falling to 4.6% of the free float by May 5 — down roughly 3.9% over the past month and off the mid-April peak above 5%. Borrow conditions remain extremely relaxed. The cost to borrow is just 0.44% annualised, and while it has crept up about 6.5% on the week, it barely registers as a friction cost. Availability in the lending pool is wide, with the short score declining to 36.8 from 38.1 a fortnight ago — another signal that the bears are not pressing hard into this move. The options market echoes the same mild caution: the put/call ratio nudged up to 0.44 after earnings, modestly above its 20-day average of 0.42 by roughly 1.4 standard deviations, far from a panicked positioning extreme. The 52-week high on the PCR is 0.63 — today's reading barely registers by comparison. Positioning looks reactive rather than structural.
The Street's verdict is firmly in neutral. The consensus sits at Hold, with 31 analysts holding that rating against just three Outperforms. The mean price target of $52.76 implies around 13% upside from Wednesday's close — but that gap reflects how far the stock has fallen, not a surge in bullish conviction. Recent analyst activity has been mixed in direction but consistent in tone: caution. Mizuho downgraded to Neutral in mid-April, cutting its target from $60 to $50, citing competitive headwinds. BofA and Cantor Fitzgerald both lifted their targets — BofA to $55 and Cantor to $54 — while holding Neutral ratings; higher targets but no conviction change. Truist kept a Sell, raising its target to $45 from $39, which now sits almost exactly where the stock is trading. RBC's Daniel Perlin reiterated Outperform at $59 on May 6, one of the few upbeat voices, but it was a reaffirmation rather than a new call. On valuation, the stock trades at a PE of 8.5x and EV/EBITDA of 6.7x — multiples that rank well on an EV/EBIT factor score (82nd percentile), but the forward EPS growth score sits at just the 15th percentile, which explains why the cheap multiple hasn't attracted buyers. The bull case rests on leadership change and strategic repositioning; the bear case points to slowing branded checkout growth and an intensifying competitive environment in fintech.
Insider activity adds one more note of caution. On April 29, Executive Vice President Frank Keller sold 10,000 shares at $50 in a single transaction worth $500,000, alongside smaller routine disposals from the Chief Accounting Officer. These followed a cluster of smaller sells on April 15. The 90-day net insider share count is technically positive — mostly a function of stock awards — but the actual open-market transactions in April point in one direction. The trades are not company-defining in scale, and significance scores are low, but the pattern of steady selling above $47-$50 is worth noting as the stock now trades below those levels.
The next scheduled print is May 19 — just under two weeks away. With the UK probe freshly disclosed, the Q1 outcome still being digested, and the new CEO mid-restructuring, that event becomes less a routine update and more a forum for management to reframe the narrative for investors who are, as at least one analyst explicitly noted this week, running short on patience.
See the live data behind this article on ORTEX.
Open PYPL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
